Pharmaceutical sector

An Expert's View about Medical, Health and Cosmetics Products in Turkey

Posted on: 27 Nov 2011

Pharmaceutical industry has a production structure which has high level of technology and automation. Approximately 25.000 people is employed in the sector. Pharmaceuticals industry due to its nature is one of the industries which has the high proportion of personnel (50%) with university education.

Pharmaceutical sector in Turkey Production of pharmaceutical preparations done in pharmaceuticals laboratories between years 1928-1950 had been increased with the establishment of local and foreign invested plants starting from year 1952, which is the start for the ?fabrication period? of the Turkish pharmaceuticals industry. Market overview Within the period after year 1984 to date, investments of foreign capital companies have been increased and especially after year 1990, 19 foreign capital firms have been entered into Turkish Pharmaceuticals market. 134 companies are operating in Turkey. Two of these companies, Social Security?s Institution Pharmaceuticals Plant and Ministry of Defence Army Pharmaceuticals Plant, are publicly owned others are private enterprises. Market size of original drugs in Turkey has realized as 4,1 billion US$ in 2009 and 4 billion US$ in 2010. Pharmaceutical industry has a production structure which has high level of technology and automation. Approximately 25.000 people is employed in the sector. Pharmaceuticals industry due to its nature is one of the industries which has the high proportion of personnel (50%) with university education. The distribution of highly educated employees is: pharmacist 4,5%, doctors 3%, chemical engineer 7,5%, chemist 7%, biologist 9,5%. Pharmaceutical industry is mainly located in the Marmara Region especially in provinces of ?stanbul, Kocaeli and Tekirda?. Exports Turkish companies have managed a steady increase in their exports in recent years. In 2010 total value of pharmaceutical industry exports reached US $ 612 million. Turkey is now exporting various pharmaceutical products to 144 countries including developed countries like Germany, the USA, Switzerland, the UK, Belgium and the Netherlands. In 2009, the global pharmaceuticals market is estimated at US$ 828bn. In 2010 this market is forecast to expand by 4% to 6% on a constant-dollar basis. Considering the effect of global GDP growth, innovations and the introduction of new products, wider access to healthcare services and rising funding, the pharmaceutical market is expected to grow at a CAGR (compound annual growth rate) of 4% to 7% between 2008 and 2013. Global pharmaceutical sales are expected to reach over US$ 975bn by the end of 2013. Although the economic environment will still be a negative pressure on many developed countries, especially those with increasing budget deficits and publicly funded healthcare systems, stronger demand than expected for 2009, as well as pricing flexibility and inventory management actions in the US market lead to a positive outlook for the global pharmaceuticals market. Key opportunities ? Harmonisation with the EU and sector modernisation holding considerable potential for the Turkish market ? Significant scope for growth, given the size of the population and the current low consumption rate ? Introduction of universal health insurance coverage ? Potential for generic sector growth, with market demand patterns structured by a cost conscious government and a low-income population ? Export trade to benefit from closer links with the EU, an improvement in local industry standards and an increase in international investment ? Potential site for clinical trials ? Recent introduction of new research and development (R&D) legislation, designed to facilitate investment Latest export opportunities ? Biotechnology and Pharmaceuticals Latest export opportunities ? Turkey Getting into the market The Turkish Health legislation has been adopted from the EU Legislation. All EU standards have been adapted into the system. More about doing business in Turkey Contacts Market intelligence is critical when doing business overseas, and UKTI can provide bespoke market research and support during overseas visits though our chargeable Overseas Market Introduction Service (OMIS). To commission research or for general advice about the market, get in touch with our specialists in country - or contact your local international trade team. ? Ms Asiye Yaman Trade & Investment Adviser British Embassy Ankara - Turkey Tel: +90 312 455 3246 E-mail: Asiye.Yaman@fco.gov.uk. Contact your local international trade team Events UKTI runs a range of events for exporters, including seminars in the UK, trade missions to overseas markets and support for attendance at overseas trade shows. Latest events ? Biotechnology and Pharmaceuticals EXPOMED (Medical and surgical instruments and appliances, laboratory equipment & diagnostics) Fair Istanbul 12-15 April 2012 www.expomedistanbul.com MEDIST (Medical and surgical instruments and appliances, laboratory equipment & diagnostics) Fair, Istanbul 13-16 October 201 2 www.cnrexpo.com Useful links More about OMIS and other UKTI services for exporters
Posted: 27 November 2011

See more from Medical, Health and Cosmetics Products in Turkey

Expert Views    
F.A.Q. About Turkish Chemical Regulations   By CRAD CEVRE LTD.STI.
Medical Device sector   By UK Trade & Investment
Healthcare Sector in Turkey   By UK Trade & Investment
Healthcare sector   By UK Trade & Investment
Pharmaceutical sector   By UK Trade & Investment